Replies to post #334398 on Bioelectronics Corp (BIEL)

[Just No]

“Seems to me like a lot of stuff goes on behind the scenes that none of us know about. ”

Indeed, everything goes on behind the scenes and investors know nothing about any of it.

BIEL is completely uncommunicative. Your example here is exactly the kind of thing they could share with us. It doesn’t have to be a paid PR, it could just be a post on one of the social media platforms. Little things like this, if they are active, could help with morale. Alas, I don’t think shareholder morale is high on the list of concerns.

[beacham]

can u post the info you found on LinkedIn that demonstrates the 'checked boxes' of the link in your post? WB

[GetSeriousOK]

The assertion that Kelly Whelan has done ANYTHING for the MDR transition is laughable.

The MDR transition period timeline IS:

26 May 2026 for class III implantable custom-made devices
31 December 2027 for class III and implantable class IIb devices
31 December 2028 for non-implantable class IIb and lower risk devices
31 December 2028, for class I devices that are a higher class under the MDR.

https://www.tga.gov.au/how-we-regulate/supply-therapeutic-good/supply-medical-device/eu-mdr-transition/eu-mdr-transition-extension#:~:text=On%2015%20March%202023%2C%20the,and%20implantable%20class%20IIb%20devices

The suggestion that they have done anything in preparation for regulations that won't take effect until December 2028 does not merit further consideration. That is simply not how Kelly Whelan operates.